Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
25.42
-0.78 (-2.96%)
Feb 9, 2026, 1:16 PM EST - Market open
Alumis Market Cap
Alumis has a market cap or net worth of $3.17 billion as of February 9, 2026. Its market cap has increased by 786.30% in one year.
Market Cap
3.17B
Enterprise Value
2.92B
1-Year Change
786.30%
Ranking
Category
Stock Price
$25.42
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $3.17B, an increase of 251.27%. That is a compound annual growth rate of 118.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 3.26B | 220.43% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centessa Pharmaceuticals | 3.43B |
| Arcutis Biotherapeutics | 3.35B |
| Denali Therapeutics | 3.29B |
| Viking Therapeutics | 3.21B |
| Xenon Pharmaceuticals | 3.20B |
| Legend Biotech | 3.16B |
| Vera Therapeutics | 3.09B |
| Edgewise Therapeutics | 3.08B |